Quality of life with palbociclib plus fulvestrant in previously treated hormone receptor–positive, her2-negative metastatic breast cancer: patient-reported outcomes from the PALOMA-3 trial

Company Name

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Vestibulum porta libero erat. Nullam at ipsum quis felis egestas vulputate nec nec ligula.

April 18, 2016

tony w

Annals of Oncology